Scientists at The Wistar Institute have identified a combination treatment that overcomes two of the biggest barriers to immunotherapy in glioblastoma.
Combination therapy overcomes immunotherapy resistance in glioblastoma
- Post author:admin
- Post published:
- Post category:uncategorized